关注
keisuke shigeta
keisuke shigeta
未知所在单位机构
在 keio.jp 的电子邮件经过验证
标题
引用次数
引用次数
年份
High absolute monocyte count predicts poor clinical outcome in patients with castration-resistant prostate cancer treated with docetaxel chemotherapy
K Shigeta, T Kosaka, S Kitano, Y Yasumizu, Y Miyazaki, R Mizuno, ...
Annals of surgical oncology 23, 4115-4122, 2016
472016
The pretreatment neutrophil-to-lymphocyte ratio is a novel biomarker for predicting clinical responses to pembrolizumab in platinum-resistant metastatic urothelial carcinoma …
K Ogihara, E Kikuchi, K Shigeta, T Okabe, S Hattori, R Yamashita, ...
Urologic Oncology: Seminars and Original Investigations 38 (6), 602. e1-602. e10, 2020
392020
Predictive factors for severe and febrile neutropenia during docetaxel chemotherapy for castration-resistant prostate cancer
K Shigeta, T Kosaka, S Yazawa, Y Yasumizu, R Mizuno, H Nagata, ...
International journal of clinical oncology 20, 605-612, 2015
372015
The conditional survival with time of intravesical recurrence of upper tract urothelial carcinoma
K Shigeta, E Kikuchi, M Hagiwara, T Ando, R Mizuno, T Abe, S Mikami, ...
The Journal of Urology 198 (6), 1278-1285, 2017
362017
Clinical utility of the Vesical Imaging-Reporting and Data System for muscle-invasive bladder cancer between radiologists and urologists based on multiparametric MRI including …
Y Arita, K Shigeta, H Akita, T Suzuki, R Kufukihara, TC Kwee, R Ishii, ...
European radiology 31, 875-883, 2021
342021
Bacillus Calmette–Guérin‐unresponsive non‐muscle‐invasive bladder cancer: Its definition and future therapeutic strategies
E Kikuchi, N Hayakawa, K Fukumoto, K Shigeta, K Matsumoto
International Journal of Urology 27 (2), 108-116, 2020
262020
Role of the MUC1‐C oncoprotein in the acquisition of cisplatin resistance by urothelial carcinoma
K Shigeta, M Hasegawa, E Kikuchi, Y Yasumizu, T Kosaka, R Mizuno, ...
Cancer science 111 (10), 3639-3652, 2020
242020
IDH2 stabilizes HIF‐1α‐induced metabolic reprogramming and promotes chemoresistance in urothelial cancer
K Shigeta, M Hasegawa, T Hishiki, Y Naito, Y Baba, S Mikami, ...
The EMBO Journal 42 (4), e110620, 2023
222023
Prolonged pneumoperitoneum time is an independent risk factor for intravesical recurrence after laparoscopic radical nephroureterectomy in upper tract urothelial carcinoma
K Shigeta, E Kikuchi, M Hagiwara, T Ando, R Mizuno, A Miyajima, ...
Surgical Oncology 26 (1), 73-79, 2017
202017
Does neoadjuvant chemotherapy have therapeutic benefit for node-positive upper tract urothelial carcinoma? Results of a multi-center cohort study
K Shigeta, K Matsumoto, K Ogihara, T Murakami, T Anno, K Umeda, ...
Urologic Oncology: Seminars and Original Investigations 40 (3), 105. e19-105 …, 2022
172022
Long-term oncologic outcomes of laparoscopic versus open radical nephroureterectomy for patients with T3N0M0 upper tract urothelial carcinoma: a multicenter cohort study with …
K Shigeta, E Kikuchi, T Abe, M Hagiwara, K Ogihara, T Anno, K Umeda, ...
Annals of surgical oncology 26, 3774-3781, 2019
152019
A novel risk-based approach simulating oncological surveillance after radical nephroureterectomy in patients with upper tract urothelial carcinoma
K Shigeta, E Kikuchi, T Abe, M Hagiwara, K Ogihara, T Anno, K Umeda, ...
European urology oncology 3 (6), 756-763, 2020
132020
Castration-resistant prostate cancer patients who had poor response on first androgen deprivation therapy would obtain certain clinical benefit from early docetaxel administration
K Shigeta, T Kosaka, H Hongo, Y Yanai, K Matsumoto, S Morita, R Mizuno, ...
International Journal of Clinical Oncology 24, 546-553, 2019
132019
Significance of prophylactic urethrectomy at the time of radical cystectomy for bladder cancer
K Hakozaki, E Kikuchi, K Ogihara, K Shigeta, T Abe, Y Miyazaki, ...
Japanese journal of clinical oncology 51 (2), 287-295, 2021
122021
Risk for intravesical recurrence of bladder cancer stratified by the results on two consecutive UroVysion fluorescence in situ hybridization tests: a prospective follow-up …
A Ikeda, T Kojima, K Kawai, S Hinotsu, N Keino, K Shiga, H Miyake, ...
International Journal of Clinical Oncology 25, 1163-1169, 2020
122020
Diagnostic performance of the vesical imaging-reporting and data system for detecting muscle-invasive bladder cancer in real clinical settings: Comparison with diagnostic …
R Kufukihara, E Kikuchi, K Shigeta, K Ogihara, Y Arita, H Akita, T Suzuki, ...
Urologic Oncology: Seminars and Original Investigations 40 (2), 61. e1-61. e8, 2022
112022
Evaluating the oncological outcomes of pure laparoscopic radical nephroureterectomy performed for upper-tract urothelial carcinoma patients: a multicenter cohort study adjusted …
K Shigeta, K Matsumoto, T Takeda, S Hattori, G Kaneko, M Matsushima, ...
Annals of Surgical Oncology 28, 465-473, 2021
112021
Accidental hypothermia treated by hemodialysis in the acute phase: three case reports and a review of the literature
T Murakami, T Yoshida, A Kurokochi, K Takamatsu, Y Teranishi, ...
Internal Medicine 58 (18), 2743-2748, 2019
112019
The clinicopathological characteristics of muscle‐invasive bladder recurrence in upper tract urothelial carcinoma
K Shigeta, K Matsumoto, K Ogihara, T Murakami, T Anno, K Umeda, ...
Cancer science 112 (3), 1084-1094, 2021
102021
Momentum dependence of pseudo-gap and superconducting gap in variation theory
T Watanabe, H Yokoyama, K Shigeta, M Ogata
New Journal of Physics 11 (7), 075011, 2009
102009
系统目前无法执行此操作,请稍后再试。
文章 1–20